These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 8038709)
21. [The effect of IL-1 receptor antagonist on bleomycin-induced pulmonary fibrosis]. He B; Zhao GR; Liu XM Zhonghua Jie He He Hu Xi Za Zhi; 1994 Feb; 17(1):21-3, 61. PubMed ID: 7521798 [TBL] [Abstract][Full Text] [Related]
22. Detection and characterization of IL-1 receptor antagonist in tissues from healthy rabbits: IL-1 receptor antagonist is probably involved in health. Matsukawa A; Fukumoto T; Maeda T; Ohkawara S; Yoshinaga M Cytokine; 1997 May; 9(5):307-15. PubMed ID: 9195129 [TBL] [Abstract][Full Text] [Related]
23. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism]. Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587 [TBL] [Abstract][Full Text] [Related]
25. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism. Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of granuloma formation induced by potassium permanganate in the mouse by a specific human recombinant receptor antagonist for interleukin-1 (hrIL-1ra). Conti P; Panara MR; Fridas S; Barbacane RC; Grilli A; Placido FC; Reale M; Fiore S Cell Immunol; 1993 Apr; 147(2):446-57. PubMed ID: 8384086 [TBL] [Abstract][Full Text] [Related]
27. The role of interleukin-1 in host responses to infectious diseases. Dinarello CA Infect Agents Dis; 1992 Oct; 1(5):227-36. PubMed ID: 1344662 [TBL] [Abstract][Full Text] [Related]
28. Evidence of a pharmacogenomic response to interleukin-l receptor antagonist in rheumatoid arthritis. Camp NJ; Cox A; di Giovine FS; McCabe D; Rich W; Duff GW Genes Immun; 2005 Sep; 6(6):467-71. PubMed ID: 15931231 [TBL] [Abstract][Full Text] [Related]
29. Extracellular release of the type I intracellular IL-1 receptor antagonist from human airway epithelial cells: differential effects of IL-4, IL-13, IFN-gamma, and corticosteroids. Levine SJ; Wu T; Shelhamer JH J Immunol; 1997 Jun; 158(12):5949-57. PubMed ID: 9190949 [TBL] [Abstract][Full Text] [Related]
30. Prolonged systemic expression of human IL-1 receptor antagonist (hIL-1ra) in mice reconstituted with hematopoietic cells transduced with a retrovirus carrying the hIL-1ra cDNA. Boggs SS; Patrene KD; Mueller GM; Evans CH; Doughty LA; Robbins PD Gene Ther; 1995 Nov; 2(9):632-8. PubMed ID: 8548552 [TBL] [Abstract][Full Text] [Related]
31. A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores. Jiang Y; Genant HK; Watt I; Cobby M; Bresnihan B; Aitchison R; McCabe D Arthritis Rheum; 2000 May; 43(5):1001-9. PubMed ID: 10817552 [TBL] [Abstract][Full Text] [Related]
32. Interleukin 1 receptor antagonist inhibits the augmentation of metastasis induced by interleukin 1 or lipopolysaccharide in a human melanoma/nude mouse system. Chirivi RG; Garofalo A; Padura IM; Mantovani A; Giavazzi R Cancer Res; 1993 Oct; 53(20):5051-4. PubMed ID: 8267795 [TBL] [Abstract][Full Text] [Related]
37. Role of interleukin-1 and the therapeutic potential of interleukin-1 receptor antagonist in sepsis. Fisher CJ; Opal SM; Lowry SF; Sadoff JC; LaBrecque JF; Donovan HC; Lookabaugh JL; Lemke J; Pribble JP; Stromatt SC Circ Shock; 1994 Sep; 44(1):1-8. PubMed ID: 7704933 [TBL] [Abstract][Full Text] [Related]
38. Monotonicity of interleukin-1 receptor-ligand binding with respect to antagonist in the presence of decoy receptor. Gnacadja G; Shoshitaishvili A; Gresser MJ; Varnum B; Balaban D; Durst M; Vezina C; Li Y J Theor Biol; 2007 Feb; 244(3):478-88. PubMed ID: 17011587 [TBL] [Abstract][Full Text] [Related]
39. Induction of interleukin 1 receptor antagonist after interleukin 1 therapy in patients with cancer. Kopp WC; Urba WJ; Rager HC; Alvord WG; Oppenheim JJ; Smith JW; Longo DL Clin Cancer Res; 1996 Mar; 2(3):501-6. PubMed ID: 9816196 [TBL] [Abstract][Full Text] [Related]
40. Interleukin-1 receptor antagonist transiently impairs antibacterial defense but not survival in murine pneumococcal pneumonia. Rijneveld AW; Florquin S; Speelman P; Edwards CK; Dinarello CA; van der Poll T Eur Cytokine Netw; 2003; 14(4):242-5. PubMed ID: 14715417 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]